Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey

Therapeutic Advances in Psychopharmacology
Robin EmsleyEMEA ADHES group

Abstract

Poor adherence to antipsychotic treatment is a widespread problem within schizophrenia therapy with serious consequences including increased risks of relapse and rehospitalization. Mounting evidence supports the key roles that nurses play in monitoring patient progress and facilitating long-term treatment adherence. The Adherencia Terapéutica en la Esquizofrenia (ADHES) nurses' survey was designed to assess the opinions of nurses on the causes and management of partial/nonadherence to antipsychotic medication. A questionnaire-based cross-sectional survey of 4120 nurses from Europe, the Middle East and Africa. Interpretation of results was based on a descriptive comparison of responses. Nurses perceived 54% of patients seen in the preceding month to be partially/nonadherent to treatment. Most nurses (90%) reported some level of experience with administration of long-acting injectable (LAI) antipsychotics, with 24% of nurses administering >10 injections per month. The majority (85%) of nurses surveyed believed that improving adherence would improve patient outcomes. Nearly half (49%) reported that most of their patients depend on a family member or other nonprofessional carer to remind them to take their medication as prescribed....Continue Reading

References

Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·M Knapp
Oct 16, 1999·Journal of Advanced Nursing·R GrayK Gournay
Apr 1, 2003·International Journal of Mental Health Nursing·Brenda HappellJaya Pinikahana
Sep 6, 2003·International Journal of Mental Health Nursing·Tim CoombsRhonda Griffiths
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Martin KnappPablo Lapuerta
Aug 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Richard GrayKevin Gournay
Aug 5, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Peter J WeidenJulie Locklear
Aug 5, 2006·Schizophrenia Bulletin·Martijn J KikkertRichard J Gray
Aug 8, 2006·The Journal of Clinical Psychiatry·Haya Ascher-SvanumChristian R Dolder
Jun 21, 2007·Schizophrenia Bulletin·Steven C Marcus, Mark Olfson
Sep 4, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·Dawn I VelliganAlexander L Miller
Oct 31, 2008·Patient Education and Counseling·Sally Wai-Chi ChanWilson Tam
Sep 15, 2009·Primary Care Companion to the Journal of Clinical Psychiatry·Prakash S MasandJohn M Kane
May 28, 2010·The British Journal of Psychiatry. Supplement·Thomas R E BarnesCarol Paton
May 28, 2010·The British Journal of Psychiatry. Supplement·Richard GrayTim Newey
May 28, 2010·The British Journal of Psychiatry. Supplement·John M Kane, Carlos Garcia-Ribera
Jan 16, 2010·International Journal of Mental Health Nursing·Richard GrayChristoph Abderhalden
Apr 3, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Suzanne M HardemanMeera Narasimhan
Jan 14, 2011·The Journal of Clinical Psychiatry·Donald C GoffOliver Freudenreich
Jan 11, 2011·Journal of Psychiatric and Mental Health Nursing·L BowersC Theodoridou
May 17, 2011·Patient Preference and Adherence·François CaroliAntonio Delgado
Jul 16, 2011·Clinical Practice and Epidemiology in Mental Health : CP & EMH·José Manuel MontesJerónimo Saiz-Ruiz
Jul 26, 2014·Patient Related Outcome Measures·Peter M HaddadJan Scott
May 7, 2015·Journal of Psychiatric and Mental Health Nursing·A SvettiniA Schreiner

❮ Previous
Next ❯

Citations

Aug 10, 2018·Journal of Clinical Nursing·Saurav GhimireSyed Tabish R Zaidi
Aug 2, 2017·Journal of Medical Economics·Thomas R EinarsonPieter J T Dries
Dec 8, 2017·International Journal of Clinical Pharmacy·Saurav GhimireSyed Tabish R Zaidi
Feb 9, 2021·CNS Neuroscience & Therapeutics·William Ak-Lam LoUNKNOWN Hong Kong Association of Psychosocial Rehabilitation (HKAPR)

❮ Previous
Next ❯

Software Mentioned

ADHES

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here